A decade of incremental advances in radiopharmaceuticals: a promising future ahead

Yu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou · 2024

Read A decade of incremental advances in radiopharmaceuticals: a promising future ahead by Yu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11616306.txt.

Description

Yu Xiong and co-authors survey a decade of growth in radiopharmaceuticals, drugs labeled with radioisotopes for imaging or therapy. Their 2024 letter focuses on radionuclide drug conjugates, precision drugs that carry a radioactive payload to a target. Two approved products showed the approach can work well in patients.

The authors counted trials of such conjugates over ten years using an industry database. A few hundred trials were found, yet barely half remain active, and most finished trials sit in early phases. The letter frames this as steady, incremental progress rather than a breakthrough wave. It argues the field's promise is real but young, with many candidates still proving safety and benefit. The survey gives clinicians and investors a grounded map of where the area stands.

Catalog record

CREATORYu Xiong, Hui Jian, Xiaowen Han, Lizhi Li, Liangxue Zhou
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE6 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11616306

Browse the full library · About the Tower of Babel